For Q3 2024, Rivian reported lower revenue than expected, and it posted larger-than-expected losses on earnings-per-share ...
Carlyle Group reports strong Q3 earnings, with distributable EPS beating consensus and total assets under management climbing ...
SAN FRANCISCO — SAN FRANCISCO — Nektar Therapeutics (NKTR) on Thursday reported a loss of $37.1 million in its third quarter. On a per-share basis, the San Francisco-based company said it had a loss ...
Unity (U) has published its earnings report for Q3 2024. In it, we see that the company behind the popular video game ...
Palantir's strong Q3 results, potential upside from the Presidential Election and focus on efficiency make it a strong buy ...
"This quarter we have made progress against our key objectives and have seen meaningful progress on our Gen 2 R1 cost structure due to the new technologies incorporated into the vehicle and ...
Over the past year, within retail pharmacy and IDNs, the U.S. hepatitis B market dose volume grew 23% year over year in Q3, while HEPLISAV-B dose volume grew 27%. These trends support our long-term ...
TXO Partners' strong oil revenue is overshadowed by declining gas sales and rising expenses. Find out why TXO stock gets a ...
Coupang reports Q3 results, net revenues up 27%, gross profit up 45%, active customers up 11%, adjusted EPS beats consensus.